Apieron Receives FDA Approval

Today Apieron received notification of FDA approval for the new Apieron Insight eNO System. This was the result of a long journey for Bhairavi and myself. We were absolutely thrilled to hear the official word the day before AAAI in Philadephia. That means we can take orders for this product. We first started this quest in 2001 and are thrilled to get to this point. Finally, physicians can truly understand and manage asthma for the millions of people in the US and around the world that suffer from this disease.

We thank all those at Apieron who worked so hard to develop and commercialize the technology. You believed in us and put your heart into your work, spending countless hours in every phase of process: R&D, product & process development, clinical, regulatory, marketing, legal, reimbursement, finance, and manufacturing. So many partners worked with us on every phase - some for little more than the promise of a great dream. Our initial and current investors helped not only with money, but with time, commitment and expertise. We appreciate all your help and are excited about getting this in the hands of allergists, pulmonologists, pediatrians, GPs, nurses and technicians can make a huge difference for the 20 million asthma sufferers in the US.

Imagine the opportunity to create a brand new market with a revolutionary product. The Apieron Insight is the first step in turning the art of asthma management into a science.

So many people supported us that it will take 3 days of calls to thank everyone. This an amazing point because it removes the one risk that we could not control.

Now it's execution time - hit the the pedal to the metal!